Search research articles
Contact Us
Filters
Showing results (41-50 of 275) with videos related to
Page
of 28
Sort By:
Leukemia
|
April 23, 2022
Cytogenetics or MRD in B-cell ALL. Do both reign supreme?
Yishai Ofran, Jacob M Rowe
Current Opinion in Hematology
|
December 27, 2018
Shifting therapeutic paradigms in induction and consolidation for older adults with acute myeloid leukemia
Tsila Zuckerman, Jacob M Rowe
Current Opinion in Hematology
|
January 10, 2015
Introducing minimal residual disease in acute myeloid leukemia
Yishai Ofran, Jacob M Rowe
Haematologica
|
January 2, 2025
Hematopoietic cell transplantation soon after first relapse in acute myeloid leukemia - the CONS
Yishai Ofran, Jacob M Rowe
F1000Prime Reports
|
September 4, 2014
Pathogenesis and prognostication in acute lymphoblastic leukemia
Tsila Zuckerman, Jacob M Rowe
Acta Haematologica
|
September 18, 2014
Acute myeloid leukemia in adolescents and young adults: challenging aspects
Yishai Ofran, Jacob M Rowe
Blood
|
December 15, 2015
Introduction to the review series on advances in acute myeloid leukemia (AML)
Bob Löwenberg, Jacob M Rowe
Expert Opinion on Biological Therapy
|
November 3, 2017
Inotuzumab ozogamicin for the treatment of acute lymphoblastic leukemia
Ariella Tvito, Jacob M Rowe
Current Opinion in Hematology
|
January 27, 2007
Alternative donor transplantation in acute myeloid leukemia: which source and when?
Tsila Zuckerman, Jacob M Rowe
Clinical Reviews in Allergy & Immunology
|
May 20, 2009
Hematopoetic stem cell transplantation in neutrophil disorders: severe congenital neutropenia, leukocyte adhesion deficiency and chronic granulomatous disease
Ronit Elhasid, Jacob M Rowe
Page
of 28
Search research articles
Search
Showing results (41-50 of 275) with videos related to
Sort By:
Page
of 28
Leukemia
|
April 23, 2022
Cytogenetics or MRD in B-cell ALL. Do both reign supreme?
Yishai Ofran, Jacob M Rowe
Current Opinion in Hematology
|
December 27, 2018
Shifting therapeutic paradigms in induction and consolidation for older adults with acute myeloid leukemia
Tsila Zuckerman, Jacob M Rowe
Current Opinion in Hematology
|
January 10, 2015
Introducing minimal residual disease in acute myeloid leukemia
Yishai Ofran, Jacob M Rowe
Haematologica
|
January 2, 2025
Hematopoietic cell transplantation soon after first relapse in acute myeloid leukemia - the CONS
Yishai Ofran, Jacob M Rowe
F1000Prime Reports
|
September 4, 2014
Pathogenesis and prognostication in acute lymphoblastic leukemia
Tsila Zuckerman, Jacob M Rowe
Acta Haematologica
|
September 18, 2014
Acute myeloid leukemia in adolescents and young adults: challenging aspects
Yishai Ofran, Jacob M Rowe
Blood
|
December 15, 2015
Introduction to the review series on advances in acute myeloid leukemia (AML)
Bob Löwenberg, Jacob M Rowe
Expert Opinion on Biological Therapy
|
November 3, 2017
Inotuzumab ozogamicin for the treatment of acute lymphoblastic leukemia
Ariella Tvito, Jacob M Rowe
Current Opinion in Hematology
|
January 27, 2007
Alternative donor transplantation in acute myeloid leukemia: which source and when?
Tsila Zuckerman, Jacob M Rowe
Clinical Reviews in Allergy & Immunology
|
May 20, 2009
Hematopoetic stem cell transplantation in neutrophil disorders: severe congenital neutropenia, leukocyte adhesion deficiency and chronic granulomatous disease
Ronit Elhasid, Jacob M Rowe
Page
of 28